Doctor profile · Federal record
Dr. TARIQ AHMAD, M.D.
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · Internal Medicine Physician · NEW HAVEN, CT
- NPI 1104955699
- Accepts Medicare
- MIPS 71.7 / 100 · 2023
- 20 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
333 CEDAR ST.
NEW HAVEN, CT 065208017
(203) 785-7191
fax (203) 785-2917 - Mailing address
-
PO BOX 208017, 333 CEDAR ST.
NEW HAVEN, CT 065208017
Credentials & registration
- NPI registered
- March 2007 — 19 yrs on file
- Profile last updated
- July 14, 2016
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State licenses (2)
- Connecticut #053951 · Massachusetts #228737
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1104955699. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
99
Distinct HCPCS
3
Medicare allowed
$13,541
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 71 | 33 | $126 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 16 | 13 | $151 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 12 | 12 | $183 |
In context: peer comparison
Among 28 peers in this city , average services per provider: 106. This provider delivers 0.9× the peer median.Open Payments
Industry payments received
All-time total
$41,852
Transactions
29
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 6 | $12,843.11 | |
| Eli Lilly and Company | 7 | $11,810.00 | |
| Edwards Lifesciences Corporation | 2 | $10,464.12 | |
| Lilly USA, LLC | 1 | $3,600.00 | |
| AstraZeneca UK Limited | 1 | $1,611.00 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $1,362.49 | |
| Abbott Laboratories | 1 | $131.44 | |
| HEARTFLOW, INC. | 1 | $29.66 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
98
Patients
0
Total drug cost
$35,296
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Farxiga (Dapagliflozin Propanediol) | Brand | 17 | 0 | $14,476 |
| Entresto (Sacubitril/Valsartan) | Brand | 16 | 0 | $18,872 |
| Metoprolol Succinate | Generic | 16 | 0 | $334 |
| Bumetanide | Generic | 15 | 0 | $1,261 |
| Spironolactone | Generic | 12 | 0 | $172 |
| Lisinopril | Generic | 11 | 0 | $66 |
| Losartan Potassium | Generic | 11 | 0 | $114 |